Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
The patent covers devices comprising arrays of single molecules, including polynucleotides; methods for producing the devices; and their subsequent use. with the Breaking Science News daily newsletter ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果